Estimating The Costs Of Specialist Out-Patient Services In A Public Hospital

Abstract

A LT H 1 7 ( 2 0 1 4 ) A 7 1 9 -A 8 1 3where the costs were allocated to the different cost-centres. Capital costs were annualised cost of capital item with life expectancy of more than 1 year and recurrent cost were all inputs consumed within a year. Total costs were then allocated to the in-patient and out-patient services based on historical financial data with a ratio of 1: 4. This was then followed by a stepwise approach of allocating the ancillary department cost centres to the clinical department cost centres. The unit cost per patient visit was calculated based on the number of visits for each department. Base year of 2010 was used to calculate the cost and patients visits. Costs were calculated from the perspective of the hospital. Results: The cost per visit to the out-patient department averaged at MYR 96.83 (USD 29.34). The cost per visit to the medical department and surgical department was MYR 138.66 (USD 42.02) and 273.39 (USD 82.84) respectively. ConClusions: The findings provide an estimate of the costs for out-patient visit. At the current minimal fee of MYR 5.00 (USD 1.5), the Ministry of Health is subsidising more than 95.0% of the health care cost for each patient. These estimates provide the policy-makers with an understanding of the cost data should they need to establish a cost basis for payment rates.

A Systems Thinking Analysis of Healthcare Supply and Demand Management

“…The Malaysian government is currently providing low-cost medical services to its citizens. A large proportion of the healthcare budget is used to cover approximately 95 per cent of visiting patients' actual medical costs [20]. This broad coverage by health providers is the reason for the growing number of patients seeking treatment at public hospitals.…”

Bone Targeting Agents in Prevention of Skeletal-Related Events in Metastatic Cancers of Solid Tumours: An Economic Evaluation

“…The costs used in this analysis were based on MOH Consumer Price Guide from Pharmaceutical Services Program (2018), Malaysian DRG Casemix costing (severity illness 2), MOH Investigation Charges from website (2018), published literature using local data (Lee WC et al, 2016, Zainal R et al, 2014, Dranitsaris G et al, 2011, Hwa YS et al, 2011 and personal communication with pharmacists from National Cancer Institute, Malaysia. Direct medical costs included were cost of drugs, cost of procedures such as IV and subcutaneous administration of drugs, cost of investigations such as renal profile, cost of SRE related management (pathological fracture, radiotherapy to the bone and spinal cord compression requiring instrumentation), cost of specialist clinic follow-ups and palliative care.…”